The invention relates to a composition for the release of an active ingredient, comprising a porous matrix, a filled carrier in the matrix and the active ingredient in the carrier. The invention is suitable for the treatment of bone cancers.

A process for producing a glazed ceramic body, in which a glazing material is applied to a non-densely sintered substrate material and the substrate material and the glazing material are subjected to a heat treatment in order to obtain the glazed body.

The present invention relates to a combined warmer and seat fumigator using bioceramics and, more specifically, to a combined warmer and seat fumigator using bioceramics, the combined warmer and seat fumigator being capable of carrying out both thermotherapy and fumigation therapy, having excellent heat insulation, ultralight weight, nonflammability, low gas toxicity, thermal conductivity and deodorizability, and having immune function improvement and inflammation alleviation efficacy through far infrared ray emissivity, radiant energy, anion generation and antibacterial ability.

The present invention provides a zirconia sintered body that has less excess material to be removed when making a prosthesis by milling, providing a reduction of work time, more durability for a working tool, and a faster treatment for patients, and that undergoes little deformation during firing, and provides enhanced aesthetics. The present invention relates to a columnar zirconia sintered body having a base and a side face, the base having a surface shape that is neither square nor rectangular but has at least one straight portion.

Bioactive, ceramic medical cements and methods for its use in treatment of bones and teeth in mammals are disclosed. This cement is non-exothermic and non-toxic, based upon setting of hydraulic ceramic compounds containing calcia, alumina, and silica phases. The self-hardening cement sets in vivo and in high humidity environments, and can be used in vivo without being easily washed out of the site. It also has dimensional stability, is resistant to acids present in an infection site or supragingivally, and has biocompatibility advantages of low inflammation and the formation of calcification layers in direct apposition to body tissue. Options include the addition of various radiopaque materials, and a variety of delivery systems including powder and liquid, capsule or pouch delivery, multiple pastes, or a unitary paste.

A method of manufacture of a powder comprising, or consisting essentially of, microspheres, the method comprising: providing a feed powder; and applying at least one spheroidisation flame to the powder. The powder may be suitable for use in medical and/or non-medical applications.

Provided is a zirconia sintered body that suppresses discoloration due to porcelain. The zirconia sintered body comprises at least one of a coloring agent A: erbium oxide and a coloring agent B: nickel oxide, and a composite oxide of zirconium and vanadium.

Methods for improving the wear performance of silicon nitride and/or other ceramic materials, particularly to make them more suitable for use in manufacturing biomedical implants.

The invention relates to a composition for the release of an active ingredient, comprising a porous matrix, a filled carrier in the matrix and the active ingredient in the carrier. The invention is suitable for the treatment of bone cancers.

The invention discloses micron-nano pore gradient oxide ceramic films with biological activity, which are prepared by the following methods: The surface structures are biomedical engineering materials; Inorganic precursor coating solutions or the organic precursor coating solutions are prepared with or without micron and nanopore additives; The surface structures of the substrate are treated in the following steps: (1) The surfaces of the substrate are coated by the inorganic precursor coating solutions or the organic precursor coating solutions with or without micron and nanopore additives; (2) The substrate with coatings are dried, sintered, naturally cooled, and cleaned. (3) The biomedical engineering materials with the micron-nanopore gradient oxide ceramic films, especially biomimetic micro-nanoporous gradient alumina film, yttrium partially stabilized zirconia film, and alumina doped yttrium partially stabilized zirconia films in this invention greatly improve biocompatibility and biological activity.